Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): an Open-Label, Multicenter, Randomized, Controlled Trial. King Abdullah International Medical Research Center , King Saud Bin Abdulaziz University for Health Sciences , Altayib Hadeel , Albayat Hawra , Alharbi Faisal , Ghalilah Khalid , Al Arfaj Abdulmajid , AlJishi Jumana , Alarfaj Abdullatif , Alqahtani Hajar , Almutairi Badriah M. , Almaghaslah Manar , Alyahya Nawaf M. , Bawazir Abdullah , AlEisa Saud , King Abdulaziz Medical City , Alharbi Malak , Ministry of National Guard Health Affairs , King Saud Bin Abdulaziz University for Health Sciences-Jeddah , Alotaibi Athari , Alqahtani Nasser , King Abdulaziz Medical City, Ministry of National Guard Health Affairs Social Science Research Network（2021）
关键词
Favipiravir, Hydroxychloroquine, COVID-19, SARS-CoV-2, Moderate-to-severe
AI 理解论文
溯源树
样例
